Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of Henderson recommended that dividends be paid for 2023

10/25/24 HNFG

Promomed reported for 6 months of 2024 by RAS

10/25/24 PRMD

Board of Directors of Mordovian Energy Supply Company recommended dividends

10/25/24 MRSB

EL5-Energo's for 9 months of 2024 output grew by 3.1%

10/25/24 ELFV

TGC-2 reported for 9 months of 2024 by RAS

10/25/24 TGKB

ZIL reported for 9 months of 2024 by RAS

10/25/24 ZILL

Board of Directors of LUKOIL recommended dividends

10/25/24 LKOH

Kamaz and Sistema unveiled a prototype hydrogen truck

10/25/24 AFKS

Kamaz and Sistema unveiled a prototype hydrogen truck

10/25/24 KMAZ

VSZ reported for 9 months of 2024 by RAS

10/25/24 VSYD